177 related articles for article (PubMed ID: 29703172)
1. The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.
Healy MA; Morris AM; Abrahamse P; Ward KC; Kato I; Veenstra CM
BMC Cancer; 2018 Apr; 18(1):481. PubMed ID: 29703172
[TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Colorectal Cancer Care in the United States: 1990-2010.
Murphy CC; Harlan LC; Lund JL; Lynch CF; Geiger AM
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26206950
[TBL] [Abstract][Full Text] [Related]
4. Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data.
Jagsi R; Abrahamse P; Hawley ST; Graff JJ; Hamilton AS; Katz SJ
Cancer; 2012 Jan; 118(2):333-41. PubMed ID: 21717446
[TBL] [Abstract][Full Text] [Related]
5. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
Wang K; Sheets NC; Basak R; Chen RC
Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
[TBL] [Abstract][Full Text] [Related]
6. Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients.
Lund JL; Stürmer T; Sanoff HK; Brookhart A; Sandler RS; Warren JL
Cancer; 2013 Jun; 119(11):2038-47. PubMed ID: 23512326
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Peer Support on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary Care.
Kanters AE; Morris AM; Abrahamse PH; Mody L; Suwanabol PA
Dis Colon Rectum; 2018 Jul; 61(7):817-823. PubMed ID: 29771795
[TBL] [Abstract][Full Text] [Related]
8. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.
Sanoff HK; Carpenter WR; Stürmer T; Goldberg RM; Martin CF; Fine JP; McCleary NJ; Meyerhardt JA; Niland J; Kahn KL; Schymura MJ; Schrag D
J Clin Oncol; 2012 Jul; 30(21):2624-34. PubMed ID: 22665536
[TBL] [Abstract][Full Text] [Related]
9. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries.
Walker GV; Giordano SH; Williams M; Jiang J; Niu J; MacKinnon J; Anderson P; Wohler B; Sinclair AH; Boscoe FP; Schymura MJ; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):686-93. PubMed ID: 23773392
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer.
Obeidat NA; Pradel FG; Zuckerman IH; DeLisle S; Mullins CD
Am J Geriatr Pharmacother; 2009 Dec; 7(6):343-54. PubMed ID: 20129255
[TBL] [Abstract][Full Text] [Related]
11. Comparison of SEER Treatment Data With Medicare Claims.
Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
[TBL] [Abstract][Full Text] [Related]
12. Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population.
Rasco DW; Yan J; Xie Y; Dowell JE; Gerber DE
J Thorac Oncol; 2010 Oct; 5(10):1529-35. PubMed ID: 20631635
[TBL] [Abstract][Full Text] [Related]
13. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
Panchal JM; Lairson DR; Chan W; Du XL
Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
[TBL] [Abstract][Full Text] [Related]
14. Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy.
Freedman RA; Vaz-Luis I; Barry WT; Lii H; Lin NU; Winer EP; Keating NL
Breast Cancer Res Treat; 2014 Jun; 145(2):491-501. PubMed ID: 24756187
[TBL] [Abstract][Full Text] [Related]
15. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
16. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.
Macleod LC; Yabes JG; Yu M; Fam MM; Hale NE; Turner RM; Lopa SH; Gingrich JR; Borza T; Skolarus TA; Davies BJ; Jacobs BL
Urol Oncol; 2019 Jul; 37(7):462-469. PubMed ID: 31053530
[TBL] [Abstract][Full Text] [Related]
17. Association of Cumulative Social Risk and Social Support With Receipt of Chemotherapy Among Patients With Advanced Colorectal Cancer.
Davis RE; Trickey AW; Abrahamse P; Kato I; Ward K; Morris AM
JAMA Netw Open; 2021 Jun; 4(6):e2113533. PubMed ID: 34106262
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity.
Lemmens VE; van Halteren AH; Janssen-Heijnen ML; Vreugdenhil G; Repelaer van Driel OJ; Coebergh JW
Ann Oncol; 2005 May; 16(5):767-72. PubMed ID: 15817594
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
